1 / 25

7th ACCP Conference on Antithrombotic and Thrombolytic Therapy:

7th ACCP Conference on Antithrombotic and Thrombolytic Therapy:. Evidence-Based Guidelines. Grade 1 Recommendations. RCT = randomized controlled trial. Grade 2 Recommendations. RCT = randomized controlled trial. Treatment of Venous Thromboembolic Disease.

peers
Télécharger la présentation

7th ACCP Conference on Antithrombotic and Thrombolytic Therapy:

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. 7th ACCP Conference on Antithrombotic and Thrombolytic Therapy: Evidence-Based Guidelines

  2. Grade 1 Recommendations RCT = randomized controlled trial

  3. Grade 2 Recommendations RCT = randomized controlled trial

  4. Treatment of Venous Thromboembolic Disease

  5. Initial Therapy for Acute DVT of the Leg • We recommend that patients receive anticoagulants as soon as the diagnosis of DVT is confirmed • Interim treatment should be started if suspicion is high and confirmation is delayed

  6. Guidelines for Initial Treatment

  7. Initial UFH or LMWH Therapy

  8. Initial UFH or LMWH Therapy, continued

  9. Systemic Thrombolysis as Initial Therapy

  10. Systemic Thrombolysis as Initial Therapy, continued

  11. Long-term Therapy for DVT of the Leg

  12. Long-term Therapy for DVT of the Leg, continued *Established LMWH regimens for long-term treatment: dalteparin, 200 IU/kg body weight qd for 1 month, then 150 IU/kg qd; or tinzaparin, 175 IU/kg body weight SC qd.

  13. Long-term Therapy for DVT of the Leg, continued

  14. Long-term Therapy for DVT of the Leg, continued

  15. Initial Therapy for PE: LMWH Or UFH Therapy

  16. Initial Therapy for PE: Thrombolytic Agents

  17. Initial Therapy for PE: Additional Recommendations

  18. Initial Therapy for PE: Additional Recommendations, continued

  19. Long-Term Therapy for PE: VKA Therapy

  20. Long-Term Therapy for PE:VKA Therapy, continued

  21. Long-Term Therapy for PE:VKA Therapy, continued

  22. Postthrombotic Syndrome

  23. Other Thrombotic Conditions

  24. Other Thrombotic Conditions, continued

  25. Other Thrombotic Conditions, continued

More Related